Relay Therapeutics: president and CEO Sanjiv Patel sold 48,199 shares

What happened

• The filing says Sanjiv Patel, president and CEO and a director, sold 48,199 shares in an open-market sale on Oct 7, 2026, for total proceeds of $872,402 at a weighted average price of $18.10 per share.

Key details

• Transaction date and prices: Oct 7, 2026; executed in multiple trades at prices ranging from $17.87 to $18.46, weighted average $18.10 (footnote F2).
• Plan: The filing says the transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on Oct 30, 2025 (footnote F1).
• Trusts and ownership: The filing says the shares sold are held in irrevocable trusts for the benefit of the reporting person's family members; an independent trustee is trustee of the trusts, and the reporting person disclaims beneficial ownership of these securities (footnote F3).
• Shares owned after the transaction: The filing does not state shares owned following the transaction.
• Filing timing: The Form 4 was filed on Oct 8, 2026, for an Oct 7, 2026 transaction; the filing does not indicate a late filing.

Why it may matter

• The filing reports a market sale completed under a pre-existing Rule 10b5-1 plan and executed in multiple trades at prices listed above.
• A filing does not show why the insider traded or why the company acted.